Literature DB >> 3327455

Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.

D A Spandidos1, A Pintzas, A Kakkanas, M Yiagnisis, H Mahera, E Patra, N J Agnantis.   

Abstract

Expression of the c-myc gene in human breast lesions and in adjacent normal tissue was studied by immunohistochemical analysis. The previously described monoclonal antibody Myc1-9E10 (1) which recognizes the p62 c-myc protein was used in paraffin tissue sections. A total of 101 cases of breast disease examined included 38 simple and complex cystic disease, 18 simple and hyperplastic fibroadenomas, 36 ductal and lobular carcinomas and 9 in situ carcinomas. Whereas the adjacent normal tissue was slightly positive, 25 out of 38 cystic disease, 7 out of 18 fibroadenoma, 36 out of 36 carcinoma and 9 out of 9 in situ carcinoma specimens showed moderate to high levels of p62 c-myc expression as indicated by staining intensity. These results suggest that the c-myc protein may play a role in breast neoplasia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3327455

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma.

Authors:  Lixing Zhan; Avi Rosenberg; Kenneth C Bergami; Min Yu; Zhenyu Xuan; Aron B Jaffe; Craig Allred; Senthil K Muthuswamy
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

2.  Cooverexpression of EpCAM and c-myc genes in malignant breast tumours.

Authors:  Samira Sadeghi; Zohreh Hojati; Hossein Tabatabaeian
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

3.  Translational control of the undifferentiated phenotype in ER‑positive breast tumor cells: Cytoplasmic localization of ERα and impact of IRES inhibition.

Authors:  Christos Vaklavas; Kurt R Zinn; Sharon L Samuel; Zheng Meng; William E Grizzle; Hyoungsoo Choi; Scott W Blume
Journal:  Oncol Rep       Date:  2018-03-23       Impact factor: 3.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.